Table 2.
Differences in baseline health-related quality of life according to anaemia status and NYHA class
| Anaemic (n= 220) | Non-anaemic (n= 221) | P (anaemic vs. non-anaemic) | NYHA III (n= 377) | NYHA II (n= 82) | P (NYHA III vs. NYHA II) | |
|---|---|---|---|---|---|---|
| HRQoL: EQ-5D | ||||||
| Visual Analogue Scale, mean ± SEM | 53.0 ± 1.1 | 55.6 ± 1.1 | 0.093 | 52.5 ± 0.8 | 62.4 ± 1.9 | <0.001 |
| Index score (×100), mean ± SEM) | 66.2 ± 1.0 | 70.7 ± 1.1 | 0.002 | 66.7 ± 0.8 | 76.5 ± 1.6 | <0.001 |
| HRQoL: KCCQ | ||||||
| Overall summary score, mean ± SEM | 49.3 ± 1.2 | 55.7 ± 1.3 | <0.001 | 49.4 ± 0.9 | 66.8 ± 1.9 | <0.001 |
| Clinical summary score, mean ± SEM | 52.4 ± 1.2 | 58.6 ± 1.3 | <0.001 | 52.0 ± 0.9 | 71.8 ± 1.8 | <0.001 |
| Total symptom score, mean ± SEM | 56.3 ± 1.3 | 61.6 ± 1.4 | <0.005 | 55.5 ± 1.0 | 75.2 ± 1.9 | <0.001 |
NYHA, New York Heart Association; EQ-5D, Euro QoL 5 Dimensions; KCCQ, Kansas City Cardiomyopathy Questionnaire.